Alvotech
ALVO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $157.4M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVOW
Q2 2025 vs. Q1 2025
How the institutions holding Alvotech changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 51 | 53 | +2 |
| Shares | 16.7M | 17.3M | +589.4K (+3.5%) |
| Value | $159.2M | $156.0M | −$3.25M (−2.0%) |
New holders (7)
Institutions that held Alvotech at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Heights Capital Management, Inc | 1,090,664 | $9.95M | 3.11% |
| Gilder Gagnon Howe & Co LLC | 195,345 | $1.78M | 0.02% |
| Norges Bank | 180,000 | $1.66M | 0.00% |
| Steadtrust LLC | 35,395 | $322.8K | 0.25% |
| LPL Financial LLC | 21,206 | $193.4K | 0.00% |
| Balyasny Asset Management LLC | 14,134 | $128.9K | 0.00% |
| Jones Financial Companies LLLP | 451 | $4.12K | 0.00% |
Sold out (5)
Institutions that held Alvotech at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| National Asset Management, Inc. | 35,395 | $342.3K |
| SIH Partners, LLLP | 19,000 | $183.7K |
| ProShare Advisors LLC | 13,600 | $131.5K |
| Ronald Blue Trust, Inc. | 811 | $7.84K |
| Coldstream Capital Management Inc | 56 | $542 |